SCHEMBL809913

SCHEMBL809913

CC(=O)C(C)Oc1ccc(OCC(=O)O)cc1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.46
PTGDR2 Q9Y5Y4 1/20 0.45
ALDH1A1 P00352 2/20 0.44
PPARD Q03181 1/20 0.44
TSHR P16473 4/20 0.43
MCL1 Q07820 1/20 0.43
PTPN7 P35236 1/20 0.43
LMNA P02545 1/20 0.42
KDM4E B2RXH2 1/20 0.41
MAPT P10636 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYSLTR2 Q9NS75 1/20 0.41
CYSLTR1 Q9Y271 1/20 0.41
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NR4A1 P22736 1/20 0.40
APEX1 P27695 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAPK1 P28482 1/20 0.40
FFAR1 O14842 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13418134 0.89 PPARD (0.40) HTTPTGDR2ALDH1A1PPARDLMNA
SCHEMBL8528987 0.81 PTGDR2 (0.55) PTGDR2ALDH1A1PPARDTSHRMCL1
SCHEMBL810141 0.80 ALDH1A1 (0.40) HTTALDH1A1PPARDTSHRKDM4E
SCHEMBL810034 0.79 ALDH1A1 (0.57) HTTALDH1A1PPARDTSHRMCL1
SCHEMBL13418164 0.75 PTGDR2 (0.47) PTGDR2ALDH1A1PPARDTSHRMCL1
SCHEMBL8528993 0.74 PTPN7 (0.58) ALDH1A1PPARDTSHRMCL1PTPN7
SCHEMBL4147094 0.74 KDM4E (0.59) HTTPTGDR2ALDH1A1PPARDLMNA
SCHEMBL810011 0.74 CYSLTR2 (0.52) PTGDR2PPARDTSHRLMNAMAPT
SCHEMBL809926 0.73 ALDH1A1 (0.50) PTGDR2ALDH1A1PPARDTSHRMCL1
SCHEMBL711082 0.73 ALDH1A1 (0.73) ALDH1A1MCL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902319-B2 Unsymmetrical aromatic ether diacids and absorbable polymers therefrom BEZWADA BIOMEDICAL, LLC (US) 2011-03-08 US disclosed
US-20100113592-A1 UNSYMMETRICAL AROMATIC ETHER DIACIDS AND ABSORBABLE POLYMERS THEREFROM BEZWADA BIOMEDICAL, LLC (US) 2010-05-06 US disclosed
US-7671168-B2 Unsymmetrical aromatic ether diacids and absorbable polymers therefrom BEZWADA BIOMEDICAL, LLC (US) 2010-03-02 US disclosed
US-20070141113-A1 UNSYMMETRICAL AROMATIC ETHER DIACIDS AND ABSORBABLE POLYMERS THEREFROM BEZWADA BIOMEDICAL, LLC (US) 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113592-A1 UNSYMMETRICAL AROMATIC ETHER DIACIDS AND ABSORBABLE POLYMERS THEREFROM DDT, ACMSD, HPD HTT 2397/4885PTGDR2 1438/4885ALDH1A1 935/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.